The role of endogenous serotonin in methamphetamine‐induced neurotoxicity to dopamine nerve endings of the striatum
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
J. Neurochem.(2010)115, 595–605. Methamphetamine (METH) is a neurotoxic drug of abuse that damages the dopamine (DA) neuronal system in a highly delimited manner. The brain structure most affected by METH is the striatum where long‐term DA depletion and microglial activation are maximal. Endogenous DA has been implicated as a critical participant in METH‐induced neurotoxicity, most likely as a substrate for non‐enzymatic oxidation by METH‐generated reactive oxygen species. The striatum is also extensively innervated by serotonin (5HT) nerve endings and this neurochemical system is modified by METH in much the same manner as seen in DA nerve endings (i.e., increased release of 5HT, loss of function in tryptophan hydroxylase and the serotonin transporter, long‐term depletion of 5HT stores). 5HT can also be modified by reactive oxygen species to form highly reactive species that damage neurons but its role in METH neurotoxicity has not been assessed. Increases in 5HT levels with 5‐hydroxytryptophan do not change METH‐induced neurotoxicity to the DA nerve endings as revealed by reductions in DA, tyrosine hydroxylase and dopamine transporter levels. Partial reductions in 5HT with p‐chlorophenylalanine are without effect on METH toxicity, despite the fact that p‐chlorophenylalanine largely prevents METH‐induced hyperthermia. Mice lacking the gene for brain tryptophan hydroxylase 2 are devoid of brain 5HT and respond to METH in the same manner as wild‐type controls, despite showing enhanced drug‐induced hyperthermia. Taken together, the present results indicate that endogenous 5HT does not appear to play a role in METH‐induced damage to DA nerve endings of the striatum.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steinbusch, H. W. M. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90146-9 · Cited by 2,415
New Insights into the Mechanism of Action of Amphetamines
Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105140 · Cited by 731
Yadav, V. K., Oury, F., Suda, N., Liu, Z.-W., Gao, X.-B., Confavreux, C., Klemenhagen, K. C., Tanaka, K. F., Gingrich, J. A., Guo, X. E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.06.051 · Cited by 661
Kuczenski, R., Segal, D., Cho, A., & Melega, W. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-02-01308.1995 · Cited by 376 · cited 1×
“This is surprising because METH is a powerful releaser of 5HT (Berger et al. 1992; Kuczenski et al. 1995; Wall et al. 1995; Cass 2000) and it disrupts pre-synaptic 5HT status in much the same manner seen for DA.”
BackgroundCadet, J. L., Jayanthi, S., & Deng, X. (2003) · The FASEB Journal · doi:10.1096/fj.03-0073rev · Cited by 286
Wall, S. C., Gu, H., & Rudnick, G. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08574-8 · Cited by 183
Lmx1b, Pet-1, and Nkx2.2 Coordinately Specify Serotonergic Neurotransmitter Phenotype
Cheng, L., Chen, C.-L., Luo, P., Tan, M., Qiu, M., Johnson, R., & Ma, Q. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-31-09961.2003 · Cited by 177 · cited 1×
“2 (Cheng et al. 2003), all of which show severe reductions in CNS 5HT content because of a near-complete absence of central 5HT neurons.”
BackgroundDeficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice
Gutknecht, L., Waider, J., Kraft, S., Kriegebaum, C., Holtmann, B., Reif, A., Schmitt, A., & Lesch, K.-P. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0096-6 · Cited by 173 · cited 1×
“Gutknecht et al. (2008) published a paper on a TPH2 knockout mouse that offered limited phenotype characterization.”
BackgroundOxidation of serotonin by superoxide radical: Implications to neurodegenerative brain disorders
Wrona, M. Z., & Dryhurst, G. (1998) · Chemical Research in Toxicology · doi:10.1021/tx970185w · Cited by 105
Cited by
Marble Burying and Nestlet Shredding as Tests of Repetitive, Compulsive-like Behaviors in Mice
Angoa-Pérez, M., Kane, M. J., Briggs, D. I., Francescutti, D. M., & Kuhn, D. M. (2013) · Journal of Visualized Experiments · doi:10.3791/50978 · Cited by 388
Self-citationExaggerated aggression and decreased anxiety in mice deficient in brain serotonin
Mosienko, V, Bert, B., Beis, D., Matthes, S., Fink, H., Bader, M., & Alenina, N. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.44 · Cited by 269
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms
Moratalla, R., Khairnar, A., Simola, N., Granado, N., García-Montes, J. R., Porceddu, P. F., Tizabi, Y., Costa, G., & Morelli, M. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.011 · Cited by 225
“…cells 2.0–3.0 mM for 24 h Huang et al. (2015) Mice 20 mg/kg, s.c Sriram et al. (2006) and Kelly et al. (2012) Mice 3 4 mg/kg, i.p., at 2 h intervals Thomas et al. (2010) and Angoa-Pérez et al. (2013) Mice 3 5 mg/kg or 3 10 mg/kg, i.p, at 2–3 h intervals Granado et al. (2010, 2011a,b),…”
InfluentialA review of treatment options for co-occurring methamphetamine use disorders and depression
Hellem, T. L., Lundberg, K. J., & Renshaw, P. F. (2015) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000058 · Cited by 51
Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study
Hellem, T. L., Sung, Y.-H., Shi, X.-F., Pett, M. A., Latendresse, G., Morgan, J., Huber, R. S., Kuykendall, D., Lundberg, K. J., & Renshaw, P. F. (2015) · Journal of Dual Diagnosis · doi:10.1080/15504263.2015.1100471 · Cited by 49
Metadata
- Authors
- Thomas, D. M., Pérez, M. A., Francescutti‐Verbeem, D. M., Shah, M. M., & Kuhn, D. M.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2010-09-06
- Volume
- 115
- Issue
- 3
- Pages
- 595-605
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1879874234
- Cited by
- 60
- References
- 9
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.